115 related articles for article (PubMed ID: 3775075)
1. Adenocarcinoma of the stomach: autopsy observations with therapeutic implications for the radiation oncologist.
Wisbeck WM; Becher EM; Russell AH
Radiother Oncol; 1986 Sep; 7(1):13-8. PubMed ID: 3775075
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
3. Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study.
Roukos DH; Lorenz M; Karakostas K; Paraschou P; Batsis C; Kappas AM
Br J Cancer; 2001 Jun; 84(12):1602-9. PubMed ID: 11401312
[TBL] [Abstract][Full Text] [Related]
4. Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy.
Gunderson LL; Sosin H
Int J Radiat Oncol Biol Phys; 1982 Jan; 8(1):1-11. PubMed ID: 7061243
[TBL] [Abstract][Full Text] [Related]
5. Histologic features of gastric cancer in relation to patterns of spread.
Nihei Z; Hirayama R; Sakamoto M; Mishima Y
Acta Chir Scand; 1989; 155(1):43-6. PubMed ID: 2929203
[TBL] [Abstract][Full Text] [Related]
6. Adenocarcinoma of the colon: an autopsy study with implications for new therapeutic strategies.
Russell AH; Pelton J; Reheis CE; Wisbeck WM; Tong DY; Dawson LE
Cancer; 1985 Sep; 56(6):1446-51. PubMed ID: 4027878
[TBL] [Abstract][Full Text] [Related]
7. Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer.
Graziosi L; Cantarella F; Mingrone E; Gunnellini M; Cavazzoni E; Liberati M; Donini A
Ann Ital Chir; 2013; 84(5):551-6. PubMed ID: 24140896
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal recurrence in serosa-negative gastric adenocarcinoma after curative surgery.
Wu CC; Chen JH; Huang KH; Fang WL; Wu CW; Lo SS; Hsieh MC; Shen KH; Li AF
Hepatogastroenterology; 2011; 58(109):1119-22. PubMed ID: 21937361
[TBL] [Abstract][Full Text] [Related]
9. Resection-line involvement in gastric cancer patients undergoing curative resections: implications for clinical management.
Cascinu S; Giordani P; Catalano V; Agostinelli R; Catalano G
Jpn J Clin Oncol; 1999 Jun; 29(6):291-3. PubMed ID: 10418557
[TBL] [Abstract][Full Text] [Related]
10. [Clinico-pathological study on recurrent gastric cancer after curative resection].
Takeshita K; Habu H; Sunagawa M; Saitoh N; Satoh Y; Endoh M
Nihon Geka Gakkai Zasshi; 1988 Feb; 89(2):173-80. PubMed ID: 2834631
[TBL] [Abstract][Full Text] [Related]
11. Lauren Histologic Type Is the Most Important Factor Associated With Pattern of Recurrence Following Resection of Gastric Adenocarcinoma.
Lee JH; Chang KK; Yoon C; Tang LH; Strong VE; Yoon SS
Ann Surg; 2018 Jan; 267(1):105-113. PubMed ID: 27759618
[TBL] [Abstract][Full Text] [Related]
12. Distinct recurrence pattern and outcome of adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach.
Saito H; Fukumoto Y; Osaki T; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
World J Surg; 2006 Oct; 30(10):1864-9. PubMed ID: 16983479
[TBL] [Abstract][Full Text] [Related]
13. Magnitude of serosal changes predicts peritoneal recurrence of gastric cancer.
Bando E; Kawamura T; Kinoshita K; Takahashi S; Maeda A; Osada S; Tsubosa Y; Yamaguchi S; Uesaka K; Yonemura Y
J Am Coll Surg; 2003 Aug; 197(2):212-22. PubMed ID: 12892799
[TBL] [Abstract][Full Text] [Related]
14. Shifting proportions of gastric adenocarcinomas.
Salvon-Harman JC; Cady B; Nikulasson S; Khettry U; Stone MD; Lavin P
Arch Surg; 1994 Apr; 129(4):381-8; discussion 388-9. PubMed ID: 7512326
[TBL] [Abstract][Full Text] [Related]
15. Predictive Value of the Neutrophil/Lymphocyte Ratio in Peritoneal and/or Metastatic Disease at Staging Laparoscopy for Gastric and Esophageal Adenocarcinoma.
Grenader T; Plotkin Y; Mohammadi B; Dawas K; Hashemi M; Mughal M; Bridgewater JA
J Gastrointest Cancer; 2015 Sep; 46(3):267-71. PubMed ID: 25952408
[TBL] [Abstract][Full Text] [Related]
16. [Adenocarcinomas of the distal esophagus and gastric cardia: what chemotherapy or chemoradiotherapy for recurrent or metastatic disease?].
Seitz JF; Duffaud F; Dahan L; Ries P; Ville E; Laugier R
Cancer Radiother; 2001 Nov; 5 Suppl 1():107s-112s. PubMed ID: 11797269
[TBL] [Abstract][Full Text] [Related]
17. Individualized surgical strategies for cancer of the esophagogastric junction.
Stein HJ; Feith M; Siewert JR
Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
[TBL] [Abstract][Full Text] [Related]
18. Macroscopic serosal classification predicts peritoneal recurrence for patients with gastric cancer underwent potentially curative surgery.
Sun Z; Xu YY; Wang ZN; Zhu Z; Zhang H; Huang BJ; Xu Y; Chen JQ; Xu HM
Ann Surg Oncol; 2011 Apr; 18(4):1068-80. PubMed ID: 21293933
[TBL] [Abstract][Full Text] [Related]
19. Low rates of loco-regional recurrence following extended lymph node dissection for gastric cancer.
Muratore A; Zimmitti G; Lo Tesoriere R; Mellano A; Massucco P; Capussotti L
Eur J Surg Oncol; 2009 Jun; 35(6):588-92. PubMed ID: 19162429
[TBL] [Abstract][Full Text] [Related]
20. [Contribution of endosonography to preoperative staging in esophageal and stomach cancer].
Grimm H; Soehendra N; Hamper K; Maas R
Chirurg; 1989 Oct; 60(10):684-9. PubMed ID: 2684563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
